Latest News and Press Releases

Reported positive clinical proof-of-concept data for OD-001 in a Phase 2a monotherapy trial for moderate to severe ulcerative colitis.

In a capital-constrained market with selective investment, Keiretsu Forum-MST is demonstrating how discipline produces investable companies.

East & Co. reimagines a former Boulder office building as a hospitality-focused hub for dining, wellness, events, and community gathering.

Marvel Biosciences Receives Notice of Allowance for Australian Patent Application Covering Composition of Matter for its Lead Therapeutic Candidate MB-204

BGB Group becomes BGBx, bringing consulting and communications together to help life science clients navigate complexity and deliver breakthrough results.

Dublin, May 20, 2026 (GLOBE NEWSWIRE) -- The "Healthcare Bioconvergence - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Healthcare...

Altitude Lab portfolio companies surpass $205M in funding as startups advance clinical trials, sign global pharma deals, and reshape early-stage biotech.

Fort Collins, CO, May 18, 2026 (GLOBE NEWSWIRE) -- Innosphere is proud to announce the 2026 cohort of its Life Sciences Incubator, featuring 38 startups advancing solutions across biopharma, digital...

Dublin, May 18, 2026 (GLOBE NEWSWIRE) -- The "Life Science Instrumentation Market by Technology, Application, End User - Global Forecast to 2031" has been added to ResearchAndMarkets.com's...

Odyssey Therapeutics, Inc. announces pricing of its upsized IPO of 15,500,000 shares of its common stock at an IPO price of $18 per share.